| ▲ | flobosg 5 hours ago | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the article: > This image is supposed to demonstrate that the antibody being sold works as intended. (…) Antibodies are near-ubiquitous but notoriously fickle laboratory reagents in biomedical research. For many applications, it is absolutely crucial that the antibodies that you use are selective (i.e., the antibody binds strongly to the target protein) and specific (i.e., the antibody binds to the protein of interest and little else). Antibodies showing a different picture (Western blot) than what is expected can drastically change the interpretation of the results as well as the conclusion of a study, for example. It may also encourage scientific fraud by authors by forcing them to unknowingly/coincidentally make to a blot image the same (or similar) fraudulent modifications performed by the vendor. Now I’m curious about how much of the blot photoshopping present in retracted papers can be attributed to these misleading verification data. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ▲ | raverbashing 5 hours ago | parent [-] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
I would be more worried if the blotted area was different (the dark blob) - or if data in a datasheet (something like test specificity, level of detection, etc) was wrong Now, if while preparing the images they needed to do some editorial choices (or it is well possible a person in the editorial group was told to 'enhance the images' but wasn't aware of the details) because of limitations in doing the experiment then this is probably not a big deal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||